Study Details

Back
Study ID 1517-CL-0304
Study Title A Japanese, Phase 2, Multicenter, Randomized, 4-arm Parallel, Double-blind (Arms 1-3), Open-label (Arm 4), Active-comparator (Darbepoetin Alfa) Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis-dependent Chronic Kidney Disease Patients with Anemia
Clinicaltrials.gov Identifier NCT01888445
Compound Name ASP1517 / roxadustat
Medical Indication or Disease Anemia with chronic kidney disease
Study Sponsor Astellas Pharma Inc.
Collaborator FibroGen
Study Start Date 28-Mar-2013
Study Completion Date 15-Sep-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS